Sep 08, 2020 / 04:15PM GMT
Andrew Simon Baum - Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
Delighted to introduce our first keynote of this year's session, Bristol-Myers Squibb. We have 2 representatives. We have Rupert Vessey, the President and Chief Medical Officer; we have Samit Hirawat, the Chief Medical Officer and Head of Development; and we have Tim Power, the Head of Investor Relations. So thank you for being with us and delighted that we eventually made it to make the technology work.
So look, I'm going to try and do in 40 minutes or so what you took 3 hours to do or 3 days to do in your recent R&D update, but I'm going to just hit the hotspots. If investors do have questions, then please feel free to e-mail me, [email protected], and I'll squeeze in as many as we can.
So I'm going to alternate my questions or try to between Rupert and Samit on the early and late stage of the portfolio and organization.
Bristol-Myers Squibb Co at Citi BioPharma Conference (Virtual) Transcript
Sep 08, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers